Get started
Live feed
·
PRReleasevia Quantisnow
Simulations Plus Inc. logo

Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Simulations Plus Inc. logo
SLP
Simulations Plus Inc.
Market cap
30-day
Sector
Technology
Industry
EDP Services
Follow SLPFull SLP profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLP (Simulations Plus Inc.) and more on Quantisnow.